Difficulty: Medium
Average Score: 77%
Practice
The following antibiotics interfere with bacterial translation:
Correct answer
C
Rationale
In the context of pediatric nursing and cardiovascular disorders, understanding the mechanisms of action of antibiotics is crucial for safe and effective patient care. In this question, the correct answer is C) Azithromycin. Azithromycin interferes with bacterial translation by binding to the 50S ribosomal subunit, thus inhibiting protein synthesis in susceptible bacteria.
Penicillin (Option A) works by inhibiting bacterial cell wall synthesis, targeting the enzyme transpeptidase. This mechanism is different from interfering with bacterial translation, making it an incorrect choice for this question.
Ceftriaxone (Option B) belongs to the cephalosporin class of antibiotics and works by disrupting bacterial cell wall synthesis, similar to penicillin. It does not interfere with bacterial translation, so it is not the correct answer in this case.
Ciprofloxacin (Option D) is a fluoroquinolone antibiotic that inhibits bacterial DNA synthesis by targeting DNA gyrase and topoisomerase IV. It does not interfere with bacterial translation like azithromycin does.
Educationally, understanding the specific mechanisms of action of antibiotics helps nurses make informed decisions when administering these medications to pediatric patients with cardiovascular disorders. It also reinforces the importance of selecting the right antibiotic based on the specific bacterial target to ensure optimal treatment outcomes and prevent antibiotic resistance.
Penicillin (Option A) works by inhibiting bacterial cell wall synthesis, targeting the enzyme transpeptidase. This mechanism is different from interfering with bacterial translation, making it an incorrect choice for this question.
Ceftriaxone (Option B) belongs to the cephalosporin class of antibiotics and works by disrupting bacterial cell wall synthesis, similar to penicillin. It does not interfere with bacterial translation, so it is not the correct answer in this case.
Ciprofloxacin (Option D) is a fluoroquinolone antibiotic that inhibits bacterial DNA synthesis by targeting DNA gyrase and topoisomerase IV. It does not interfere with bacterial translation like azithromycin does.
Educationally, understanding the specific mechanisms of action of antibiotics helps nurses make informed decisions when administering these medications to pediatric patients with cardiovascular disorders. It also reinforces the importance of selecting the right antibiotic based on the specific bacterial target to ensure optimal treatment outcomes and prevent antibiotic resistance.